Methods for treating a stricture with a botulinum toxin
AssigneeAllergan, Inc.
InventorsGregory Brooks, Stephen Donovan
Life of this patent
Estimating the term…
Abstract
Methods of treating a urethral stricture in a patient. The methods can include the step of administering an therapeutically effective amount of a botulinum toxin directly to a urethra of the patient, for example by use of a stent from which the botulinum toxin can elute or diffuse, thereby treating the urethra stricture.
Claims21
A method for treating a urethral stricture in a patient, the method comprising the step of administering an effective amount of a botulinum toxin directly to a urethra of the patient, wherein the patient is having or has had a stenting procedure, thereby treating the urethral stricture.
A method for treating a urethral stricture in a mammal, the method comprising the step of
- (a) administering an effective amount of a botulinum toxin directly to a urethra of the mammal;
- and
- (b) stenting the urethra.
A method for treating a urethral stricture in a patient, the method comprising the step of administering an effective amount of a botulinum toxin directly to a urethra of the patient, wherein the patient is not having a urethrotomy, thereby treating the urethral stricture.
A method for treating a urethral stricture, the method comprising the step of inserting into a urethral stricture of a patient a biodegradable stent coated with or embedded with a therapeutically effective amount of a botulinum toxin, thereby treating the urethral stricture.
Dependencies are inferred from the claim text.